Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Apr 15, 2022; 14(4): 897-919
Published online Apr 15, 2022. doi: 10.4251/wjgo.v14.i4.897
Table 5 Prognostic factors of patients with gastric cancer by univariate and multivariate analyses based on logistic regression analysis in the infiltrative growth type group
Characteristics
INFc
Univariate analysis
Multivariate analysis
HR (95%CI)
P value
HR (95%CI)
P value
Sex0.570
Male1
Female0.889 (0.592-1.335)
Age (yr)1.028 (1.009-1.047)0.0031.026 (1.004-1.049)0.021
BMI0.965 (0.915-1.017)0.184
PLR1.007 (1.004-1.010)< 0.0011.004 (1.001-1.008)0.021
ALT0.984 (0.966-1.003)0.096
Total protein0.995 (0.973-1.018)0.683
CEA1.006 (0.998-1.014)0.161
CA19-91.000 (1.000-1.006)0.0201.001 (0.999-1.004)0.387
Borrmann type< 0.0010.055
0-111
22.104 (0.574-7.708)0.2621.193 (0.290-4.903)0.807
34.298 (1.233-14.981)0.0221.781 (0.460-6.891)0.403
4-514.250 (3.837-52.919)< 0.0013.735 (0.835-16.696)0.085
Tumor location< 0.0010.059
Lower third11
Middle third2.791 (1.669-4.670)< 0.0011.952 (1.052-3.622)0.034
Upper third1.985 (0.947-4.160)0.0691.955 (0.820-4.658)0.130
Entire stomach22.330 (2.867-173.902)0.0034.687 (0.523-41.965)0.167
Tumor size (mm)1.028 (1.020-1.037)< 0.0011.004 (0.993-1.016)0.433
pTNM stage< 0.0010.028
I11
II10.667 (1.405-80.956)0.0228.549 (1.073-68.125)0.043
III45.208 (6.106-334.716)< 0.00113.795 (1.693-112.382)0.014
Histological types0.643
Well and medium differentiation1
Poor differentiation1.026 (0.656-1.604)0.912
Others0.826 (0.493-1.384)0.468
mLNR93.645 (30.921-283.603)< 0.00111.042 (2.407-50.664)0.002
Vascular infiltration< 0.0010.783
No11
Yes2.899 (1.905-4.411)1.080 (0.623-1.874)
Nerve infiltration0.0290.471
No11
Yes1.524 (1.044-2.226)1.187 (0.745-1.892)
Postoperative chemotherapy0.315
Yes1
No0.891 (0.554-1.209)